BHV-7000 not checked

Biohaven

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2/3 trial completes
Trials
4 active
9 in total · 4 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“BHV-7000 50 mg. Participants will take blinded investigational product (IP) once daily”In the company’s words, NCT06309966 on ClinicalTrials.gov
Tested for
Focal Epilepsy (3 trials), Familial Erythromelalgia
Main trialPhase 2/3
“The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.”In the company’s words, NCT06309966 on ClinicalTrials.gov
Other names
opakalim

Other drugs for Focal Epilepsy

All 9 drugs for Focal Epilepsy

Coming up3

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials9

TrialPhaseCompletesWhat it tests
Phase 2/3Active, not recruiting Oct 2026 Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Phase 2/3Active, not recruiting Dec 2026 A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Phase 2Enrolling by invitation Dec 2026 Long-term Safety and Tolerability of BHV-7000
Phase 1Active, not recruiting Nov 2027 A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia
Phase 2/3Completed 15 Jan 2025 BHV-7000 Acute Treatment of Bipolar Mania
Phase 2/3Terminated 12 Mar 2026 A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures
Phase 2Terminated 25 Apr 2025 BHV-7000 Open-Label Extension Bipolar Mania Study
Phase 2Completed 7 Nov 2025 Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression
Phase 2Completed 18 Mar 2026 Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow BHV-7000

Following is part of Solo: you see every change to BHV-7000 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in